{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:31:29Z","timestamp":1791232289329,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Ethics"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>When including participants with dementia in research, various ethical issues arise. At present, there are only a few existing dementia-specific research guidelines (Committee for Medicinal Products for Human Use\u00a0in Clinical investigation of medicines for the treatment Alzheimer\u2019s disease (Internet).<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.ema.europa.eu\/en\/clinical-investigation-medicines-treatment-alzheimers-disease\">https:\/\/www.ema.europa.eu\/en\/clinical-investigation-medicines-treatment-alzheimers-disease<\/jats:ext-link>; Food and\u00a0Drug Administration, Early\u00a0Alzheimer\u2019s Disease: Developing Drugs for Treatment Guidance for Industry [Internet].<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/alzheimers-disease-developing-drugs-treatment-guidance-industy\">http:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/alzheimers-disease-developing-drugs-treatment-guidance-industy<\/jats:ext-link>), necessitating a more systematic and comprehensive approach to this topic to help researchers and stakeholders address dementia-specific ethical issues in research. A systematic literature review provides information on the ethical issues in dementia-related research and might therefore serve as a basis to improve the ethical conduct of this research. This systematic review aims to provide a broad and unbiased overview of ethical issues in dementia research by reviewing, analysing, and coding the latest literature on the topic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a systematic review in PubMed and Google Scholar (publications in English between 2007 and 2020, no restrictions on the type of publication) of literature on research ethics in dementia research. Ethical issues in research were identified by qualitative text analysis and normative analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The literature review retrieved 110 references that together mentioned 105 ethical issues in dementia research. This set of ethical issues was structured into a matrix based on the eight major principles from a pre-existing framework on biomedical ethics (Emanuel et al.\u00a0An Ethical Framework for Biomedical Research.\u00a0in The Oxford textbook of clinical research ethics, Oxford University Press, Oxford, 2008). Consequently, subcategories were created and further categorized into dementia stages and study phases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The systematically derived matrix helps raise awareness and understanding of the complex topic of ethical issues in dementia research. The matrix can be used as a basis for researchers, policy makers and other stakeholders when planning, conducting and monitoring research, making decisions on the legal background of the topic, and creating research practice guidelines.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12910-020-00572-5","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T13:03:04Z","timestamp":1616763784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["The full spectrum of ethical issues in dementia research: findings of a systematic qualitative review"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6998-0850","authenticated-orcid":false,"given":"Tim G.","family":"G\u00f6tzelmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Strech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Kahrass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,26]]},"reference":[{"key":"572_CR1","doi-asserted-by":"crossref","unstructured":"Wimo A, J\u00f6nsson L, Bond J, Prince M, Winblad B, International AD. The worldwide economic impact of dementia 2010. Alzheimers Dement. 2013;9(1):1\u201311.","DOI":"10.1016\/j.jalz.2012.11.006"},{"issue":"1","key":"572_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","volume":"9","author":"M Prince","year":"2013","unstructured":"Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9(1):63\u201375.","journal-title":"Alzheimers Dement"},{"issue":"10","key":"572_CR3","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1017\/S1041610215000848","volume":"27","author":"RA Johnson","year":"2015","unstructured":"Johnson RA, Karlawish J. A review of ethical issues in dementia. Int Psychogeriatr. 2015;27(10):1635\u201347.","journal-title":"Int Psychogeriatr"},{"key":"572_CR4","doi-asserted-by":"crossref","unstructured":"Emanuel EJ, Grady CC, Crouch RA, Lie RK, Miller FG, Wendler DD. An Ethical Framework for Biomedical Research. In: The Oxford textbook of clinical research ethics. Oxford University Press; 2008. p. 123\u201335.","DOI":"10.1093\/oso\/9780195168655.001.0001"},{"key":"572_CR5","unstructured":"WMA - The World Medical Association-WMA Declaration of Helsinki\u2014Ethical Principles for Medical Research Involving Human Subjects [Internet]. [Cited 2019 Mar 19]. Available from: https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/."},{"key":"572_CR6","doi-asserted-by":"crossref","unstructured":"Davis DS. Ethical issues in Alzheimer\u2019s disease research involving human subjects. J Med Ethics. 2017; medethics\u20142016.","DOI":"10.1136\/medethics-2016-103392"},{"issue":"4","key":"572_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1177\/1471301207084365","volume":"6","author":"C Sherratt","year":"2007","unstructured":"Sherratt C, Soteriou T, Evans S. Ethical issues in social research involving people with dementia. Dementia. 2007;6(4):463\u201379.","journal-title":"Dementia"},{"key":"572_CR8","doi-asserted-by":"crossref","unstructured":"van der Vorm A, Vernooij-Dassen MJFJ, Kehoe PG, Rikkert MGMO, van Leeuwen E, Dekkers WJM. Ethical aspects of research into Alzheimer disease. A European Delphi Study focused on genetic and non-genetic research. J Med Ethics. 2009;35(2):140\u20134.","DOI":"10.1136\/jme.2008.025049"},{"issue":"1","key":"572_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/JGP.0b013e3181bd1de2","volume":"18","author":"BS Black","year":"2010","unstructured":"Black BS, Rabins PV, Sugarman J, Karlawish JH. Seeking assent and respecting dissent in dementia research. Am J Geriatr Psychiatry. 2010;18(1):77\u201385.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"09","key":"572_CR10","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1017\/S1041610211000433","volume":"23","author":"M-F Dubois","year":"2011","unstructured":"Dubois M-F, Bravo G, Graham J, Wildeman S, Cohen C, Painter K, et al. Comfort with proxy consent to research involving decisionally impaired older adults: do type of proxy and risk\u2013benefit profile matter? Int Psychogeriatr. 2011;23(09):1479\u201388.","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"572_CR11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/JGP.0b013e318162992d","volume":"16","author":"J Karlawish","year":"2008","unstructured":"Karlawish J, Kim SYH, Knopman D, van Dyck CH, James BD, Marson D. The views of alzheimer disease patients and their study partners on proxy consent for clinical trial enrollment. Am J Geriatr Psychiatry. 2008;16(3):240\u20137.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"7","key":"572_CR12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nrneurol.2011.76","volume":"7","author":"SYH Kim","year":"2011","unstructured":"Kim SYH. The ethics of informed consent in Alzheimer disease research. Nat Rev Neurol. 2011;7(7):410\u20134.","journal-title":"Nat Rev Neurol"},{"key":"572_CR13","doi-asserted-by":"crossref","unstructured":"Kim SYH, Kim HM, Knopman DS, De Vries R, Damschroder L, Appelbaum PS. Effect of public deliberation on attitudes toward surrogate consent for dementia research.\u2014PubMed\u2014NCBI [Internet]. [Cited 2017 Jan 4]. Available from: https:\/\/n.neurology.org\/content\/77\/24\/2097.short.","DOI":"10.1212\/WNL.0b013e31823648cb"},{"issue":"3","key":"572_CR14","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1177\/1533317508317817","volume":"23","author":"MG Olde Rikkert","year":"2008","unstructured":"Olde Rikkert MG, van der Vorm A, Burns A, Dekkers W, Robert P, Sartorius N, et al. Consensus statement on genetic research in dementia. Am J Alzheimers Dis Other Demen. 2008;23(3):262\u20136.","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"572_CR15","doi-asserted-by":"crossref","unstructured":"SYH Kim,\u00a0J Karlawish,\u00a0BE Berkman. Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials.\u2014PubMed\u2014NCBI [Internet]. [Cited 2017 Jan 4]. Available from: https:\/\/n.neurology.org\/content\/84\/14\/1488.short.","DOI":"10.1212\/WNL.0000000000001451"},{"issue":"1","key":"572_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/bmb\/ldr023","volume":"100","author":"M Arribas-Ayllon","year":"2011","unstructured":"Arribas-Ayllon M. The ethics of disclosing genetic diagnosis for Alzheimer\u2019s disease: do we need a new paradigm? Br Med Bull. 2011;100(1):7\u201321.","journal-title":"Br Med Bull"},{"issue":"1","key":"572_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/WAD.0b013e31815a9dcc","volume":"22","author":"S Chao","year":"2008","unstructured":"Chao S, Roberts JS, Marteau TM, Silliman R, Cupples LA, Green RC. Health behavior changes after genetic risk assessment for Alzheimer disease: the REVEAL study. Alzheimer Dis Assoc Disord. 2008;22(1):94\u20137.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"5","key":"572_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/GIM.0b013e3182076bf1","volume":"13","author":"KD Christensen","year":"2011","unstructured":"Christensen KD, Roberts JS, Uhlmann WR, Green RC. Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk. Genet Med. 2011;13(5):409\u201314.","journal-title":"Genet Med"},{"issue":"3","key":"572_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1056\/NEJMoa0809578","volume":"361","author":"RC Green","year":"2009","unstructured":"Green RC, Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, Brown T, et al. Disclosure of APOE genotype for risk of Alzheimer\u2019s disease. N Engl J Med. 2009;361(3):245\u201354.","journal-title":"N Engl J Med"},{"issue":"4","key":"572_CR20","doi-asserted-by":"publisher","first-page":"P123","DOI":"10.1016\/j.jalz.2012.05.323","volume":"8","author":"D Salmon","year":"2012","unstructured":"Salmon D, Lineweaver T, Bondi M, Galasko D. Knowledge of APOE genotype affects subjective and objective memory performance in healthy older adults. Alzheimers Dement J Alzheimers Assoc. 2012;8(4):P123\u20134.","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"572_CR21","doi-asserted-by":"crossref","unstructured":"West E, Stuckelberger A, Pautex S, Staaks J, Gysels M. Operationalising ethical challenges in dementia research\u2014a systematic review of current evidence. Age Ageing. 2017;1\u201310.","DOI":"10.1093\/ageing\/afw250"},{"issue":"6","key":"572_CR22","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1192\/bjp.bp.112.116335","volume":"202","author":"D Strech","year":"2013","unstructured":"Strech D, Mertz M, Knuppel H, Neitzke G, Schmidhuber M. The full spectrum of ethical issues in dementia care: systematic qualitative review. Br J Psychiatry. 2013;202(6):400\u20136.","journal-title":"Br J Psychiatry"},{"key":"572_CR23","first-page":"159","volume":"1","author":"P Mayring","year":"2004","unstructured":"Mayring P. Qualitative content analysis. Companion Qual Res. 2004;1:159\u201376.","journal-title":"Companion Qual Res"},{"issue":"10","key":"572_CR24","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.jalz.2018.05.011","volume":"14","author":"A Thorogood","year":"2018","unstructured":"Thorogood A, M\u00e4ki-Pet\u00e4j\u00e4-Leinonen A, Brodaty H, Dalp\u00e9 G, Gastmans C, Gauthier S, et al. Consent recommendations for research and international data sharing involving persons with dementia. Alzheimers Dement. 2018;14(10):1334\u201343.","journal-title":"Alzheimers Dement"},{"key":"572_CR25","unstructured":"Jack Cr, Da B, K B, Mc C, B D, Sb H, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease [Internet]. Alzheimer\u2019s & dementia: the journal of the Alzheimer\u2019s Association. 2018 [cited 2020 Sep 24]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29653606\/."},{"issue":"6","key":"572_CR26","doi-asserted-by":"publisher","first-page":"e11150","DOI":"10.1371\/journal.pone.0011150","volume":"5","author":"S Gainotti","year":"2010","unstructured":"Gainotti S, Imperatori SF, Spila-Alegiani S, Maggiore L, Galeotti F, Vanacore N, et al. How are the interests of incapacitated research participants protected through legislation? An Italian study on legal agency for dementia patients. PLoS ONE. 2010;5(6):e11150.","journal-title":"PLoS ONE"},{"issue":"8","key":"572_CR27","doi-asserted-by":"publisher","first-page":"e1001498","DOI":"10.1371\/journal.pmed.1001498","volume":"10","author":"H Kn\u00fcppel","year":"2013","unstructured":"Kn\u00fcppel H, Mertz M, Schmidhuber M, Neitzke G, Strech D. Inclusion of ethical issues in dementia guidelines: a thematic text analysis. PLoS Med. 2013;10(8):e1001498.","journal-title":"PLoS Med"},{"issue":"6","key":"572_CR28","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1177\/1740774510380241","volume":"7","author":"LC Hanson","year":"2010","unstructured":"Hanson LC, Gilliam R, Lee TJ. Successful clinical trial research in nursing homes: the improving decision-making study. Clin Trials Lond Engl. 2010;7(6):735\u201343.","journal-title":"Clin Trials Lond Engl"},{"issue":"2","key":"572_CR29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3928\/19404921-20090401-04","volume":"2","author":"L Garand","year":"2009","unstructured":"Garand L, Lingler JH, Conner KO, Dew MA. Diagnostic labels, stigma, and participation in research related to dementia and mild cognitive impairment. Res Gerontol Nurs. 2009;2(2):112\u201321.","journal-title":"Res Gerontol Nurs"},{"key":"572_CR30","doi-asserted-by":"crossref","unstructured":"Heggestad AKT, Nortvedt P, Sletteb\u00f8 Ashild. The importance of moral sensitivity when including persons with dementia in qualitative research. Nurs Ethics. 2012;0969733012455564.","DOI":"10.1177\/0969733012455564"},{"issue":"1","key":"572_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/0969733007071355","volume":"14","author":"S Slaughter","year":"2007","unstructured":"Slaughter S, Cole D, Jennings E, Reimer MA. Consent and assent to participate in research from people with dementia. Nurs Ethics. 2007;14(1):27\u201340.","journal-title":"Nurs Ethics"},{"issue":"2","key":"572_CR32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/phe\/phr013","volume":"4","author":"N Sofaer","year":"2011","unstructured":"Sofaer N, Strech D. Reasons why post-trial access to trial drugs should, or need not be ensured to research participants: a systematic review. Public Health Ethics. 2011;4(2):160\u201384.","journal-title":"Public Health Ethics"},{"issue":"2","key":"572_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.healthpol.2008.10.013","volume":"90","author":"D Strech","year":"2009","unstructured":"Strech D, Persad G, Marckmann G, Danis M. Are physicians willing to ration health care? Conflicting findings in a systematic review of survey research. Health Policy. 2009;90(2):113\u201324.","journal-title":"Health Policy"},{"key":"572_CR34","unstructured":"Europe A. Overcoming ethical challenges affecting the involvement of people with dementia in research: recognising diversity and promoting inclusive research. Luxemb Alzheimer Eur. 2019."},{"key":"572_CR35","unstructured":"Alzheimer E. Alzheimer Europe Report: The ethics of dementia research: Alzheimer Europe; 2011. 2011."},{"key":"572_CR36","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3389\/fnhum.2014.00921","volume":"8","author":"S Schicktanz","year":"2014","unstructured":"Schicktanz S, Schweda M, Ballenger JF, Fox PJ, Halpern J, Kramer JH, et al. Before it is too late: professional responsibilities in late-onset Alzheimer\u2019s research and pre-symptomatic prediction. Front Hum Neurosci. 2014;8:921.","journal-title":"Front Hum Neurosci"},{"key":"572_CR37","unstructured":"Molinuevo JL, Cami J, Carn\u00e9 X, Carrillo MC, Georges J, Isaac MB, et al. Ethical challenges in preclinical Alzheimer\u2019s disease observational studies and trials: Results of the Barcelona summit. Alzheimers Dement [Internet]. 2016 Mar [cited 2016 Apr 21]; Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1552526016000765."},{"key":"572_CR38","doi-asserted-by":"crossref","unstructured":"Harkins K, Sankar P, Sperling R, Grill JD, Green RC, Johnson KA, et al. Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants. Alzheimers Res Ther [Internet]. 2015 Dec [cited 2017 Jan 6];7(1). Available from: http:\/\/alzres.com\/content\/7\/1\/26.","DOI":"10.1186\/s13195-015-0112-7"},{"key":"572_CR39","doi-asserted-by":"crossref","unstructured":"Werner P, S S. Practical and Ethical Aspects of Advance Research Directives for Research on Healthy Aging: German and Israeli Professionals\u2019 Perspectives [Internet]. Frontiers in medicine. 2018 [cited 2020 Sep 21]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29675415\/.","DOI":"10.3389\/fmed.2018.00081"},{"issue":"1","key":"572_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/WAD.0000000000000047","volume":"29","author":"MS Cary","year":"2015","unstructured":"Cary MS, Rubright JD, Grill JD, Karlawish J. Why are spousal caregivers more prevalent than nonspousal caregivers as study partners in AD dementia clinical trials? Alzheimer Dis Assoc Disord. 2015;29(1):70\u20134.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"5","key":"572_CR41","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1177\/0969733007080206","volume":"14","author":"I Hellstr\u00f6m","year":"2007","unstructured":"Hellstr\u00f6m I, Nolan M, Nordenfelt L, Lundh U. Ethical and Methodological Issues in Interviewing Persons With Dementia. Nurs Ethics. 2007;14(5):608\u201319.","journal-title":"Nurs Ethics"},{"issue":"4","key":"572_CR42","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jagp.2013.01.027","volume":"21","author":"E Overton","year":"2013","unstructured":"Overton E, Appelbaum PS, Fisher SR, Dohan D, Roberts LW, Dunn LB. Alternative decision-makers\u2019 perspectives on assent and dissent for dementia research. Am J Geriatr Psychiatry. 2013;21(4):346\u201354.","journal-title":"Am J Geriatr Psychiatry"},{"key":"572_CR43","doi-asserted-by":"crossref","unstructured":"Grill Jd, Cg C, K H, J K. Reactions to learning a \u201cnot elevated\u201d amyloid PET result in a preclinical Alzheimer\u2019s disease trial [Internet]. Alzheimer\u2019s research & therapy. 2018 [cited 2020 Sep 21]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30579361\/.","DOI":"10.1186\/s13195-018-0452-1"},{"key":"572_CR44","doi-asserted-by":"crossref","unstructured":"Hosie A, S K, N R, I G, D P, C S, et al. Older Persons\u2019 and Their Caregivers\u2019 Perspectives and Experiences of Research Participation With Impaired Decision-Making Capacity: A Scoping Review [Internet]. The Gerontologist. 2020 [cited 2020 Sep 21]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32866239\/.","DOI":"10.1093\/geront\/gnaa118"},{"key":"572_CR45","doi-asserted-by":"crossref","unstructured":"Jongsma K, J P, S S, K R. Motivations for people with cognitive impairment to complete an advance research directive\u2014a qualitative interview study [Internet]. BMC Psychiatry. 2020 [cited 2020 Sep 21]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32641010\/.","DOI":"10.1186\/s12888-020-02741-7"},{"issue":"4","key":"572_CR46","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1177\/1476750318787005","volume":"17","author":"J Mann","year":"2019","unstructured":"Mann J, Hung L. Co-research with people living with dementia for change. Action Res. 2019;17(4):573\u201390.","journal-title":"Action Res"},{"issue":"1","key":"572_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-018-3069-6","volume":"20","author":"H Morbey","year":"2019","unstructured":"Morbey H, Harding AJ, Swarbrick C, Ahmed F, Elvish R, Keady J, et al. Involving people living with dementia in research: an accessible modified Delphi survey for core outcome set development. Trials. 2019;20(1):1\u201310.","journal-title":"Trials"},{"key":"572_CR48","unstructured":"Ries N, E M, R S-F. Planning Ahead for Dementia Research Participation: Insights from a Survey of Older Australians and Implications for Ethics, Law and Practice [Internet]. Journal of bioethical inquiry. 2019 [cited 2020 Sep 21]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31297689\/."},{"issue":"1","key":"572_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-161285","volume":"59","author":"JM Robillard","year":"2017","unstructured":"Robillard JM, Feng TL. When patient engagement and research ethics collide: lessons from a dementia forum. J Alzheimers Dis. 2017;59(1):1\u201310.","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"572_CR50","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/bioe.12195","volume":"29","author":"K Jongsma","year":"2015","unstructured":"Jongsma K, Bos W, van de Vathorst S. Morally relevant similarities and differences between children and dementia patients as research subjects: representation in legal documents and ethical guidelines: children and dementia patients as research subjects. Bioethics. 2015;29(9):662\u201370.","journal-title":"Bioethics"},{"key":"572_CR51","doi-asserted-by":"crossref","unstructured":"Alpinar-Sencan Z, S S. Addressing ethical challenges of disclosure in dementia prediction: limitations of current guidelines and suggestions to proceed [Internet]. BMC Medical Ethics. 2020 [cited 2020 Sep 21]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32393330\/.","DOI":"10.1186\/s12910-020-00476-4"},{"issue":"2","key":"572_CR52","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/17496535.2019.1580302","volume":"13","author":"JR Fletcher","year":"2019","unstructured":"Fletcher JR, Lee K, Snowden S. Uncertainties when applying the mental capacity act in dementia research: a call for researcher experiences. Ethics Soc Welf. 2019;13(2):183\u201397.","journal-title":"Ethics Soc Welf"},{"issue":"6","key":"572_CR53","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1080\/13607863.2017.1317334","volume":"22","author":"D Gove","year":"2018","unstructured":"Gove D, Diaz-Ponce A, Georges J, Moniz-Cook E, Mountain G, Chattat R, et al. Alzheimer Europe\u2019s position on involving people with dementia in research through PPI (patient and public involvement). Aging Ment Health. 2018;22(6):723\u20139.","journal-title":"Aging Ment Health"},{"issue":"3","key":"572_CR54","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11673-017-9794-9","volume":"14","author":"NM Ries","year":"2017","unstructured":"Ries NM, Thompson KA, Lowe M. Including people with dementia in research: an analysis of Australian ethical and legal rules and recommendations for reform. J Bioethical Inq. 2017;14(3):359\u201374.","journal-title":"J Bioethical Inq"},{"key":"572_CR55","first-page":"67","volume":"12","author":"A Thorogood","year":"2018","unstructured":"Thorogood A, Dalpe G, McLauchlan D, Knoppers B. Canadian consent and capacity regulation: undermining dementia research and human rights. McGill J Law Health. 2018;12:67.","journal-title":"McGill J Law Health"},{"key":"572_CR56","unstructured":"Committee for Medicinal Products for Human Use. Clinical investigation of medicines for the treatment Alzheimer\u2019s disease [Internet]. European Medicines Agency. 2018 [cited 2019 Aug 1]. Available from: https:\/\/www.ema.europa.eu\/en\/clinical-investigation-medicines-treatment-alzheimers-disease."},{"key":"572_CR57","unstructured":"Food and Drug Administration. Early Alzheimer\u2019s Disease: Developing Drugs for Treatment Guidance for Industy [Internet]. U.S. Food and Drug Administration. 2019 [cited 2019 Aug 1]. Available from: http:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/alzheimers-disease-developing-drugs-treatment-guidance-industy."}],"container-title":["BMC Medical Ethics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12910-020-00572-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12910-020-00572-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12910-020-00572-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T22:19:55Z","timestamp":1724710795000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedethics.biomedcentral.com\/articles\/10.1186\/s12910-020-00572-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,26]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["572"],"URL":"https:\/\/doi.org\/10.1186\/s12910-020-00572-5","relation":{},"ISSN":["1472-6939"],"issn-type":[{"value":"1472-6939","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,26]]},"assertion":[{"value":"20 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}